A股異動 | 華潤微(688396.SH)高開逾9% 攜手大基金加碼晶圓生產線
格隆匯6月8日丨華潤微(688396.SH)高開逾9%,報71.01元,股價創近五個半月新高,總市值937億元。華潤微昨日公吿,公司全資子公司華微控股擬與國家集成電路產業投資基金二期股份有限公司及重慶西永微電子產業園區開發有限公司共同簽署《潤西微電子(重慶)有限公司投資協議》,發起設立潤西微電子(重慶)有限公司,註冊資本擬為50億元人民幣,由項目公司投資建設12吋功率半導體晶圓生產線項目,項目計劃投資75.5億元人民幣。其中,華微控股以自有資金出資9.5億元,出資完成後佔項目公司註冊資本的19%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.